evodiamine has been researched along with Cancer of Ovary in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chai, J; Ding, H; Mao, M; Sheng, Y; Zheng, X | 1 |
Qiang, WA; Tan, W; Wang, SP; Wang, YT; Zhong, ZF | 1 |
Chen, TC; Chen, YC; Chien, CC; Wu, MS | 1 |
Cao, Z; Jin, X; Li, W; Wei, L | 1 |
4 other study(ies) available for evodiamine and Cancer of Ovary
Article | Year |
---|---|
Evodiamine inhibits malignant progression of ovarian cancer cells by regulating lncRNA-NEAT1/miR-152-3p/CDK19 axis.
Topics: Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinases; Female; Humans; MicroRNAs; Ovarian Neoplasms; RNA, Long Noncoding | 2023 |
Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ovarian Epithelial; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Mice; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Quinazolines | 2015 |
Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells.
Topics: Adenine; Anthracenes; Apoptosis; Caspase 3; Cell Line, Tumor; eIF-2 Kinase; Evodia; Female; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Membrane Potential, Mitochondrial; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Quinazolines; Signal Transduction; Structure-Activity Relationship | 2016 |
[Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase B signaling pathways].
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Drugs, Chinese Herbal; Evodia; Female; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines | 2016 |